The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

A popular drug for treating obesity and diabetes is now showing benefits in fighting a deadly liver disease. Semaglutide, marketed under names including Ozempic and Wegovy, aids weight loss and ...

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...